000851195 001__ 851195
000851195 005__ 20210129234805.0
000851195 0247_ $$2doi$$a10.1111/ene.13773
000851195 0247_ $$2ISSN$$a1351-5101
000851195 0247_ $$2ISSN$$a1468-1331
000851195 0247_ $$2ISSN$$a1471-0552
000851195 0247_ $$2pmid$$apmid:30107062
000851195 0247_ $$2WOS$$aWOS:000455803800006
000851195 037__ $$aFZJ-2018-04895
000851195 082__ $$a610
000851195 1001_ $$0P:(DE-HGF)0$$aDafsari, Haidar S.$$b0$$eCorresponding author
000851195 245__ $$aBeneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease
000851195 260__ $$aOxford$$bBlackwell Science91133$$c2019
000851195 264_1 $$2Crossref$$3online$$bWiley$$c2018-09-21
000851195 264_1 $$2Crossref$$3print$$bWiley$$c2019-02-01
000851195 264_1 $$2Crossref$$3print$$bWiley$$c2019-02-01
000851195 3367_ $$2DRIVER$$aarticle
000851195 3367_ $$2DataCite$$aOutput Types/Journal article
000851195 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1547820055_32150
000851195 3367_ $$2BibTeX$$aARTICLE
000851195 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000851195 3367_ $$00$$2EndNote$$aJournal Article
000851195 520__ $$aBackground and purposeSubthalamic nucleus (STN) deep brain stimulation (DBS) improves quality of life (QoL) and motor and non‐motor symptoms in advanced Parkinson's disease (PD). However, its effect on alexithymia and its relationship to other neuropsychiatric symptoms and QoL in PD is unclear.MethodsIn this prospective, observational study of 39 patients with PD undergoing STN‐DBS, we examined the Parkinson's Disease Questionnaire‐8 (PDQ‐8), 20‐item Toronto Alexithymia Scale (TAS‐20), Hospital Anxiety and Depression Scale (HADS), Self‐Report Manic Inventory (SRMI), Apathy Evaluation Scale (AES), Unified Parkinson's Disease Rating Scale (UPDRS) activities of daily living, UPDRS motor examination and UPDRS complications (UPDRS‐II/‐III/‐IV) and levodopa‐equivalent daily dose (LEDD) pre‐operatively and at 5‐month follow‐up. Outcome changes were tested with Wilcoxon signed‐rank or paired t‐test when parametric tests were applicable and corrected for multiple comparisons. The relationship between outcome changes was explored with bivariate correlations. Additionally, partial correlations between PDQ‐8 and TAS‐20 were computed controlling for HADS, SRMI and AES change scores. Predictor analyses for PDQ‐8 improvement were calculated for all baseline parameters.ResultsThe baseline prevalence of alexithymia was 17.9%. We observed significant beneficial effects of STN‐DBS on PDQ‐8, TAS‐20, HADS, UPDRS‐II, ‐III and ‐IV scores and significant LEDD reduction. The correlation between TAS‐20 and PDQ‐8 improvements remained significant after controlling for all other aforementioned outcomes. Predictor analyses for PDQ‐8 improvement were significant for PDQ‐8 and TAS‐20.ConclusionsThis is the first report of beneficial effects of STN‐DBS on alexithymia. Alexithymia was significantly associated with QoL outcome independent of anxiety, depression, mania and apathy. Our study highlights the importance of alexithymia for holistic assessments of DBS outcomes.
000851195 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000851195 542__ $$2Crossref$$i2018-09-21$$uhttp://doi.wiley.com/10.1002/tdm_license_1.1
000851195 542__ $$2Crossref$$i2018-09-21$$uhttp://onlinelibrary.wiley.com/termsAndConditions#vor
000851195 588__ $$aDataset connected to CrossRef
000851195 7001_ $$0P:(DE-HGF)0$$aChaudhuri, K. Ray$$b1
000851195 7001_ $$0P:(DE-HGF)0$$aMahlstedt, Picabo$$b2
000851195 7001_ $$0P:(DE-HGF)0$$aSachse, Lena$$b3
000851195 7001_ $$0P:(DE-HGF)0$$aSteffen, Julia K.$$b4
000851195 7001_ $$0P:(DE-HGF)0$$aPetry-Schmelzer, Jan Niklas$$b5
000851195 7001_ $$0P:(DE-HGF)0$$aDembek, Till A.$$b6
000851195 7001_ $$0P:(DE-HGF)0$$aReker, Paul$$b7
000851195 7001_ $$0P:(DE-Juel1)131613$$aBarbe, Michael$$b8
000851195 7001_ $$0P:(DE-HGF)0$$aVisser-Vandewalle, Veerle$$b9
000851195 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R.$$b10
000851195 7001_ $$0P:(DE-HGF)0$$aTimmermann, Lars$$b11
000851195 77318 $$2Crossref$$3journal-article$$a10.1111/ene.13773$$b: Wiley, 2018-09-21$$n2$$p222-e17$$tEuropean Journal of Neurology$$v26$$x1351-5101$$y2019
000851195 773__ $$0PERI:(DE-600)2020241-6$$a10.1111/ene.13773$$n2$$p222-e17$$tEuropean journal of neurology$$v26$$x1351-5101$$y2019
000851195 8564_ $$uhttps://juser.fz-juelich.de/record/851195/files/Dafsari_et_al-2019-European_Journal_of_Neurology.pdf$$yRestricted
000851195 8564_ $$uhttps://juser.fz-juelich.de/record/851195/files/Dafsari_et_al-2019-European_Journal_of_Neurology.pdf?subformat=pdfa$$xpdfa$$yRestricted
000851195 909CO $$ooai:juser.fz-juelich.de:851195$$pVDB
000851195 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000851195 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000851195 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000851195 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J NEUROL : 2015
000851195 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000851195 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000851195 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000851195 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000851195 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000851195 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000851195 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000851195 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000851195 9141_ $$y2019
000851195 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131613$$aForschungszentrum Jülich$$b8$$kFZJ
000851195 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b10$$kFZJ
000851195 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000851195 920__ $$lyes
000851195 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000851195 980__ $$ajournal
000851195 980__ $$aVDB
000851195 980__ $$aI:(DE-Juel1)INM-3-20090406
000851195 980__ $$aUNRESTRICTED